TherapeuticsMD (TXMD) Short-term Investments (2022)

TherapeuticsMD (TXMD) has reported Short-term Investments for 1 consecutive years, with $11.2 million the latest figure, recorded in Q4 2022.

• For the quarter ending Q4 2022, Short-term Investments changed N/A year-over-year to $11.2 million; the trailing twelve-month figure through Dec 2022 stood at $11.2 million (changed N/A YoY), and the FY2022 full-year result was $11.2 million, changed N/A from the prior year.
• Short-term Investments held at $11.2 million in Q4 2022 per TXMD's latest filing, from $11.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $11.2 million in Q2 2022 and bottomed at $11.2 million in Q2 2022.